Entering text into the input field will update the search result below

Big Biopharma in the red as investors wait for Trump's drug price plan

  • Major drug makers are under water nearing the close as skittish investors move the sidelines ahead of President Trump's plan to peg Medicare reimbursement to the lowest ex-U.S. prices from a select group of countries.
  • ETFs: BIB, GRX, THW, BME, BIS, IXJ, ARKG, IDNA, XLV, PJP, XBI, IHE, XPH
  • Takeda (TAK -0.3%), Bausch Health Companies (BHC -4.4%), Roche (OTCQX:RHHBY -1.9%), AbbVie (ABBV -1%), Allergan (AGN -0.3%), AstraZeneca (AZN -1.8%), Bristol-Myers Squibb (BMY -3.5%), GlaxoSmithKline (GSK -0.6%), Johnson & Johnson (JNJ -1.1%), Eli Lilly (LLY -4.4%), Merck (MRK -4.9%), Novo Nordisk (NVO -3%), Novartis (NVS -1.5%), Pfizer (PFE -2.7%), Teva Pharmaceutical Industries (TEVA -2.5%)

Recommended For You

Related Stocks

SymbolLast Price% Chg
BIB--
ProShares Ultra Nasdaq Biotechnology ETF
GRX--
Gabelli Healthcare & WellnessRx Trust
THW--
abrdn World Healthcare Fund
BME--
BlackRock Health Sciences Trust
BIS--
ProShares UltraShort Nasdaq Biotechnology ETF